Skip to main content

Cephea Early Feasibility Study

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Cephea Early Feasibility Study

Financial Navigation Program to Improve Understanding and Management of Financial Aspects of Cancer Care for Patients and Their Spouses

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Financial Navigation Program to Improve Understanding and Management of Financial Aspects of Cancer Care for Patients and Their Spouses

Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc)

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc)

A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infecti

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infecti

Testing Oral Decitabine and Cedazuridine (ASTX727) in Combination With Venetoclax for Higher-Risk Acute Myeloid Leukemia Patients

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Testing Oral Decitabine and Cedazuridine (ASTX727) in Combination With Venetoclax for Higher-Risk Acute Myeloid Leukemia Patients

A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid.

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid.

A Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about A Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria

A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial

Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial

Submitted by Anonymous (not verified) on Fri, 07/28/2023 - 14:45
  • Read more about Tipifarnib for the Treatment of Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With HRAS Gene Alterations, a Pediatric MATCH Treatment Trial

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 32
  • Page 33
  • Page 34
  • Page 35
  • Page 36
  • Page 37
  • Page 38
  • Page 39
  • Page 40
  • …
  • Next page Next
  • Last page Last
Subscribe to